Literature DB >> 22677178

Rotavirus immune responses and correlates of protection.

Juana Angel1, Manuel A Franco, Harry B Greenberg.   

Abstract

Selected topics in the field of rotavirus immunity are reviewed focusing on recent developments that may improve efficacy and safety of current and future vaccines. Rotaviruses (RVs) have developed multiple mechanisms to evade interferon (IFN)-mediated innate immunity. Compared to more developed regions of the world, protection induced by natural infection and vaccination is reduced in developing countries where, among other factors, high viral challenge loads are common and where infants are infected at an early age. Studies in developing countries indicate that rotavirus-specific serum IgA levels are not an optimal correlate of protection following vaccination, and better correlates need to be identified. Protection against rotavirus following vaccination is substantially heterotypic; nonetheless, a role for homotypic immunity in selection of circulating postvaccination strains needs further study.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22677178      PMCID: PMC3422408          DOI: 10.1016/j.coviro.2012.05.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  50 in total

1.  Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines.

Authors:  Sung-Sil Moon; Yuhuan Wang; Andi L Shane; Trang Nguyen; Pratima Ray; Penelope Dennehy; Luck Ju Baek; Umesh Parashar; Roger I Glass; Baoming Jiang
Journal:  Pediatr Infect Dis J       Date:  2010-10       Impact factor: 2.129

2.  Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium.

Authors:  Mark Zeller; Mustafizur Rahman; Elisabeth Heylen; Sarah De Coster; Sofie De Vos; Ingrid Arijs; Luis Novo; Natasha Verstappen; Marc Van Ranst; Jelle Matthijnssens
Journal:  Vaccine       Date:  2010-09-17       Impact factor: 3.641

3.  Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.

Authors:  K Zaman; Duc Anh Dang; John C Victor; Sunheang Shin; Md Yunus; Michael J Dallas; Goutam Podder; Dinh Thiem Vu; Thi Phuong Mai Le; Stephen P Luby; Huu Tho Le; Michele L Coia; Kristen Lewis; Stephen B Rivers; David A Sack; Florian Schödel; A Duncan Steele; Kathleen M Neuzil; Max Ciarlet
Journal:  Lancet       Date:  2010-08-06       Impact factor: 79.321

4.  Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.

Authors:  George E Armah; Samba O Sow; Robert F Breiman; Michael J Dallas; Milagritos D Tapia; Daniel R Feikin; Fred N Binka; A Duncan Steele; Kayla F Laserson; Nana A Ansah; Myron M Levine; Kristen Lewis; Michele L Coia; Margaret Attah-Poku; Joel Ojwando; Stephen B Rivers; John C Victor; Geoffrey Nyambane; Abraham Hodgson; Florian Schödel; Max Ciarlet; Kathleen M Neuzil
Journal:  Lancet       Date:  2010-08-06       Impact factor: 79.321

5.  Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4.

Authors:  Lijuan Yuan; Shinjiro Honma; Inyoung Kim; Albert Z Kapikian; Yasutaka Hoshino
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

6.  A TGF-beta mediated regulatory mechanism modulates the T cell immune response to rotavirus in adults but not in children.

Authors:  Martha C Mesa; Lina Gutiérrez; Carolina Duarte-Rey; Juana Angel; Manuel A Franco
Journal:  Virology       Date:  2010-01-22       Impact factor: 3.616

7.  Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program.

Authors:  Ricardo G Gurgel; Anna K Bohland; Sarah C F Vieira; Débora M P Oliveira; Paula B Fontes; Viviane F Barros; Marcela F Ramos; Winifred Dove; Toyoko Nakagomi; Osamu Nakagomi; Jailson B Correia; Nigel Cunliffe; Luis E Cuevas
Journal:  Gastroenterology       Date:  2009-07-24       Impact factor: 22.682

8.  Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.

Authors:  Jailson B Correia; Manish M Patel; Osamu Nakagomi; Fernanda M U Montenegro; Eliane M Germano; Nancy B Correia; Luis E Cuevas; Umesh D Parashar; Nigel A Cunliffe; Toyoko Nakagomi
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226

9.  Rotavirus antagonizes cellular antiviral responses by inhibiting the nuclear accumulation of STAT1, STAT2, and NF-kappaB.

Authors:  Gavan Holloway; Thanhmai T Truong; Barbara S Coulson
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

10.  Effect of human rotavirus vaccine on severe diarrhea in African infants.

Authors:  Shabir A Madhi; Nigel A Cunliffe; Duncan Steele; Desirée Witte; Mari Kirsten; Cheryl Louw; Bagrey Ngwira; John C Victor; Paul H Gillard; Brigitte B Cheuvart; Htay H Han; Kathleen M Neuzil
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

View more
  45 in total

1.  Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain.

Authors:  Michelle M Arnold; Mario Barro; John T Patton
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

2.  Maternal Helminth Infection Is Associated With Higher Infant Immunoglobulin A Titers to Antigen in Orally Administered Vaccines.

Authors:  Carolyn E Clark; Michael P Fay; Martha E Chico; Carlos A Sandoval; Maritza G Vaca; Alexis Boyd; Philip J Cooper; Thomas B Nutman
Journal:  J Infect Dis       Date:  2016-02-16       Impact factor: 5.226

3.  Expression of human rotavirus chimeric fusion proteins from replicating but non disseminating adenovectors and elicitation of rotavirus-specific immune responses in mice.

Authors:  Aurélie Girard; Elodie Roques; Marie-Claude St-Louis; Bernard Massie; Denis Archambault
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

4.  Multiple Introductions and Antigenic Mismatch with Vaccines May Contribute to Increased Predominance of G12P[8] Rotaviruses in the United States.

Authors:  Kristen M Ogden; Yi Tan; Asmik Akopov; Laura S Stewart; Rendie McHenry; Christopher J Fonnesbeck; Bhinnata Piya; Maximilian H Carter; Nadia B Fedorova; Rebecca A Halpin; Meghan H Shilts; Kathryn M Edwards; Daniel C Payne; Mathew D Esona; Slavica Mijatovic-Rustempasic; James D Chappell; John T Patton; Natasha B Halasa; Suman R Das
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

5.  Reinfection of adult cattle with rotavirus B during repeated outbreaks of epidemic diarrhea.

Authors:  Michiko Hayashi; Toshiaki Murakami; Yoshizumi Kuroda; Hikaru Takai; Hisahiro Ide; Ainani Awang; Tohru Suzuki; Ayako Miyazaki; Makoto Nagai; Hiroshi Tsunemitsu
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

Review 6.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

7.  Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors α4β7 and CCR9.

Authors:  Miguel Parra; Daniel Herrera; J Mauricio Calvo-Calle; Lawrence J Stern; Carlos A Parra-López; Eugene Butcher; Manuel Franco; Juana Angel
Journal:  Virology       Date:  2014-02-07       Impact factor: 3.616

8.  αvβ8 integrin-expression by BATF3-dependent dendritic cells facilitates early IgA responses to Rotavirus.

Authors:  J Nakawesi; S This; J Hütter; M Boucard-Jourdin; V Barateau; K Getachew Muleta; L J Gooday; K Fog Thomsen; A Garcias López; I Ulmert; D Poncet; B Malissen; H Greenberg; O Thaunat; T Defrance; H Paidassi; K Lahl
Journal:  Mucosal Immunol       Date:  2020-03-11       Impact factor: 7.313

9.  Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8].

Authors:  Lulu Shao; David D Fischer; Sukumar Kandasamy; Abdul Rauf; Stephanie N Langel; David E Wentworth; Karla M Stucker; Rebecca A Halpin; Ham Ching Lam; Douglas Marthaler; Linda J Saif; Anastasia N Vlasova
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

Review 10.  Rotavirus infection.

Authors:  Sue E Crawford; Sasirekha Ramani; Jacqueline E Tate; Umesh D Parashar; Lennart Svensson; Marie Hagbom; Manuel A Franco; Harry B Greenberg; Miguel O'Ryan; Gagandeep Kang; Ulrich Desselberger; Mary K Estes
Journal:  Nat Rev Dis Primers       Date:  2017-11-09       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.